Home  >  Health Check  >  Antimicrobial resistance in conflict zones
Health Check
Antimicrobial resistance in conflict zones
Health Check
Mar 25, 2026

For the last few weeks, the news has been dominated by the situation in the Middle East. Joining Claudia Hammond is BBC Health Correspondent James Gallagher who speaks with Dr Antoine Abou Fayad, a microbiologist and medicinal chemist based in Beirut, Lebanon. He reveals that war, just like the ongoing conflict in the Middle East, provides the perfect storm to accelerate the spread of multidrug-resistant infections. And nobody is safe.

Following the recent meningitis B outbreak in the UK which has killed two people and led to the rollout of vaccines and preventative antibiotics, Claudia and James discuss how meningitis outbreaks are dealt with in the ‘meningitis belt’ - an area stretching across 26 sub-Saharan African countries and talk about a new vaccine aiming to stop deadly meningitis epidemics which has been confirmed to be safe following analysis of vaccination campaigns in Nigeria and Niger.

And India's snakebite crisis is killing near sixty thousand people every year, about six people every hour. Journalist Chhavi Sachdev joins us to discuss the progress of India’s National Action Plan to tackle snakebite envenoming which launched two years ago. Also, what time of day do you exercise? Well, a new study using Fitbit-derived heart rate data has found that people who regularly exercised early in the morning were significantly less likely to have coronary artery disease, high blood pressure, Type 2 diabetes or obesity compared with people who exercised later in the day.

Presenter: Claudia Hammond Producer: Jonathan Blackwell

More Episodes



Apr 22, 2026
Making surgery safer for infants

We learn about a new injectable microgel to help reduce bleeding in infants who require surgical care. In a mice model, it reduced bleeding by at least 50%. Ashley Brown, Professor of Biomedical Engineering at North Carolina State University and UNC Chapel Hill tells presenter Claudia Hammond more about this new material her team has designed.

Joined by Professor of Global Health and Epidemiology at Boston University in the US, Dr Matthew Fox, Claudia hears about a mystery illness that is being investigated by health officials in Burundi, which has caused five deaths and sickened thirty-five people. So far lab analysis of the illness - which causes fever, vomiting, and diarrhoea - has been negative for Ebola and Marburg viruses, Rift Valley fever, and others.

We hear about influential analysis from Cochrane which has concluded that "breakthrough" Alzheimer's drugs are unlikely to benefit patients. Researchers said the impact was "well below" what was needed to make a difference to dementia patients' lives. However, their report has also provoked a vicious backlash from equally esteemed scientists who label it as fundamentally flawed.

We’re joined by health journalist Katie Silver in Mexico, who brings us the news that the President, Claudia Sheinbaum, has announced the details of a plan to introduce universal healthcare – no mean feat in country of 130 million people.

And we hear about an experiment that was done by academics to see if they could trick AI chatbots into believing in an entirely fake disease.

Presenter: Claudia Hammond Producer: Jonathan Blackwell


26min 28sec

Antimicrobial resistance in conflict zones

--:--
--:--